You are currently accessing the institutional-grade blueprint for <b>Allison Peckumn – What’s New in Diabetes?</b>. Instant digital deployment and lifetime encrypted access are guaranteed immediately upon transaction clearance.
[Instant Download]
– Immediately deliver the download link after receiving the payment
Purchase Allison Peckumn – What’s New in Diabetes? courses at here with PRICE $40 $10
- State Associations:
- AOMA – Arizona
- Faculty:
- Allison Peckumn, DO, FACE
- Duration:
- 53 Minutes
- Expiration:
- Never expires.
Description
Objectives:
-
Share new medications available for the treatment of diabetes mellitus
-
Outline new technology and its role in the management of diabetes
-
Create a better understanding of the current management of diabetes
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the American Osteopathic Association (AOA). The Arizona Osteopathic Medical Association (AOMA) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians.
Handouts
| What’s New in Diabetes.pdf (17.00 MB) | 32 Pages | Available after Purchase |
Faculty
Allison Peckumn, DO, FACE Related seminars and products: 1
Allison Peckumn, DO, FACE is board certified in internal medicine and endocrinology, diabetes, and metabolism. She recently left a position as endocrine faculty and interim program director for the endocrine fellowship at Banner University Medical Center – Phoenix, and this year has begun working for Abrazo Diabetes Care Centers. Dr. Peckumn received her medical degree from Michigan State University College of Osteopathic Medicine and completed her residency and chief residency in internal medicine as well as her fellowship in endocrinology at Banner Good Samaritan Medical Center. She is also Clinical Assistant Professor of Medicine for the University of Arizona College of Medicine Phoenix.
Dr. Peckumn has no disclosures.
Purchase Allison Peckumn – What’s New in Diabetes? courses at here with PRICE $40 $10
Trading foreign exchange, cryptocurrencies, and algorithmic assets on margin carries a high level of risk and may not be suitable for all investors. Past performance of any trading system or quantitative blueprint does not guarantee future results.<br><br><b>Asset Classification:</b>



